Antiretroviral Pregnancy Registry (APR): Multi-sponsor Registry to Detect Any Major Teratogenic Effect Involving Any of the Registry Drugs When Administered to Pregnant Women.
This study is currently recruiting participants.
Verified April 2013 by INC Research
Boehringer Ingelheim Pharmaceuticals
IPCA Laboratories Ltd.
Janssen R&D Ireland
Roche Pharma AG
Strides Arcolab Ltd.
Teva Pharmaceuticals USA
ViiV Healthcare (represented by GlaxoSmithKline)
Information provided by (Responsible Party):
First received: November 27, 2006
Last updated: April 2, 2013
Last verified: April 2013
No Study Results Posted on ClinicalTrials.gov for this Study
|Study Status:||This study is currently recruiting participants.|
|Estimated Study Completion Date:||January 2015|
|Estimated Primary Completion Date:||No date given|